Patent 10392621 was granted and assigned to SomaLogic, Inc. on August, 2019 by the United States Patent and Trademark Office.
Described herein are compositions comprising a first aptamer, second aptamer and a target that are capable of forming a ternary complex, and wherein the first aptamer and the second aptamer comprise C-5 pyrimidine modification schemes that are different, and methods of making and using such compositions.